Skip to content
10-Q

Quarterly Report

VAXXINITY, INC.

0001562762-22-000453

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Short Term Investments Q3 2022 · Sep 30, 2022 $80.23M
Current Liabilities Q3 2022 · Sep 30, 2022 $32.43M
Current Liabilities Q3 2022 · Dec 31, 2021 $27.49M
Total Liabilities Q3 2022 · Sep 30, 2022 $42.7M
Total Liabilities Q3 2022 · Dec 31, 2021 $38.05M
Current Assets Q3 2022 · Sep 30, 2022 $108.08M
Current Assets Q3 2022 · Dec 31, 2021 $154.3M
Total Assets Q3 2022 · Sep 30, 2022 $122.96M
Total Assets Q3 2022 · Dec 31, 2021 $166.67M
Revenue Q3 2022 · Jun 30, 2022 $50K
Revenue Q3 2022 · Sep 30, 2021 $67K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $144.89M
Capex Q3 2022 · Sep 30, 2021 $50K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$67.03M
Stockholders Equity restated Q3 2022 · Sep 30, 2021 −$170.92M
Stockholders Equity restated Q3 2022 · Dec 31, 2020 −$87.35M
Sga Expense restated Q3 2022 · Sep 30, 2021 $6.87M
Sga Expense Q3 2022 · Sep 30, 2021 $21.13M
Rd Expense restated Q3 2022 · Sep 30, 2021 $23.44M
Rd Expense restated Q3 2022 · Sep 30, 2021 $54.32M
Net Income Q3 2022 · Sep 30, 2021 −$30.39M
Net Income restated Q3 2022 · Sep 30, 2021 −$89.32M
Operating Income Q3 2022 · Sep 30, 2021 −$30.28M
Operating Income restated Q3 2022 · Sep 30, 2021 −$77.32M
Gross Profit Q3 2022 · Sep 30, 2021 $41K
Gross Profit Q3 2022 · Sep 30, 2021 −$1.87M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $9K
Cost Of Revenue Q3 2022 · Sep 30, 2021 $1.94M